Anticancer Drugs Oncology Pharmacology Physiotherapy Selumetinib


In this article we will discuss Selumetinib (Dosage Overview)

In this article, we will discuss Selumetinib (Dosage Overview). So, let’s get started.


Selumetinib is indicated for the treatment of pediatric patients 2 years of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN).


Recommended Dosage

The recommended dosage of Selumetinib is 25 mg/m² orally twice daily (approximately every 12 hours) until disease progression or unacceptable toxicity.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.